IRIS
MARGIOTTA, NICOLA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 9.655
AS - Asia 3.803
EU - Europa 3.294
SA - Sud America 1.102
Continente sconosciuto - Info sul continente non disponibili 348
AF - Africa 138
OC - Oceania 29
Totale 18.369
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 9.489
SG - Singapore 1.516
IT - Italia 1.108
CN - Cina 965
BR - Brasile 872
HK - Hong Kong 525
SE - Svezia 401
RU - Federazione Russa 335
FI - Finlandia 299
UA - Ucraina 291
DE - Germania 286
VN - Vietnam 212
FR - Francia 204
GB - Regno Unito 150
IN - India 111
BD - Bangladesh 93
AR - Argentina 72
CA - Canada 72
ID - Indonesia 51
MX - Messico 48
TR - Turchia 47
IQ - Iraq 44
ZA - Sudafrica 43
EC - Ecuador 40
CO - Colombia 36
NL - Olanda 35
VE - Venezuela 35
IE - Irlanda 32
ES - Italia 31
MA - Marocco 30
PK - Pakistan 30
SA - Arabia Saudita 30
PL - Polonia 25
AU - Australia 24
JP - Giappone 20
BE - Belgio 19
PH - Filippine 19
CL - Cile 18
MY - Malesia 17
UZ - Uzbekistan 16
CI - Costa d'Avorio 14
KE - Kenya 14
AT - Austria 13
JO - Giordania 12
PY - Paraguay 12
KR - Corea 10
LT - Lituania 10
IR - Iran 9
TN - Tunisia 9
BO - Bolivia 8
CZ - Repubblica Ceca 8
JM - Giamaica 8
AE - Emirati Arabi Uniti 7
AZ - Azerbaigian 7
BG - Bulgaria 7
BH - Bahrain 7
CR - Costa Rica 7
KZ - Kazakistan 7
OM - Oman 7
HN - Honduras 6
NP - Nepal 6
UY - Uruguay 6
EG - Egitto 5
ET - Etiopia 5
GT - Guatemala 5
HU - Ungheria 5
TH - Thailandia 5
TT - Trinidad e Tobago 5
CH - Svizzera 4
DZ - Algeria 4
LB - Libano 4
NG - Nigeria 4
NZ - Nuova Zelanda 4
RS - Serbia 4
AL - Albania 3
GE - Georgia 3
HR - Croazia 3
IL - Israele 3
PS - Palestinian Territory 3
PT - Portogallo 3
QA - Qatar 3
RO - Romania 3
SN - Senegal 3
SY - Repubblica araba siriana 3
BB - Barbados 2
BY - Bielorussia 2
CM - Camerun 2
EE - Estonia 2
EU - Europa 2
KN - Saint Kitts e Nevis 2
LY - Libia 2
MD - Moldavia 2
NI - Nicaragua 2
PA - Panama 2
PR - Porto Rico 2
SI - Slovenia 2
SK - Slovacchia (Repubblica Slovacca) 2
TW - Taiwan 2
AM - Armenia 1
BN - Brunei Darussalam 1
Totale 17.999
Salva come PNG Salva come JPEG
Città #
Fairfield 983
Ashburn 835
Singapore 758
Chandler 714
San Jose 682
Jacksonville 675
Woodbridge 581
Hong Kong 517
Houston 457
Milan 425
Seattle 398
Cambridge 382
Wilmington 329
Nyköping 310
Council Bluffs 281
Ann Arbor 233
Beijing 208
Nanjing 195
Lawrence 163
Roxbury 160
New York 156
Helsinki 149
Lauterbourg 145
Rome 136
Boardman 131
Bari 109
Des Moines 106
Dallas 101
Los Angeles 89
Santa Clara 79
São Paulo 79
Princeton 74
Ho Chi Minh City 70
Columbus 62
Nanchang 62
Figino 60
Brooklyn 57
Hanoi 55
San Diego 43
Buffalo 40
London 36
Rio de Janeiro 36
Chicago 35
Shenyang 35
Inglewood 34
San Francisco 32
Dublin 30
Jakarta 30
Hebei 29
Turin 29
Jiaxing 26
Dearborn 25
Munich 24
Baghdad 23
Changsha 23
Paris 23
Tianjin 23
Montreal 22
Moscow 22
Phoenix 22
Warsaw 21
Guangzhou 20
Toronto 20
Brussels 19
Amsterdam 18
Johannesburg 18
Orem 18
Quito 18
Denver 17
Kunming 17
Mexico City 17
Shanghai 17
Nuremberg 16
Tokyo 16
Boston 15
Brasília 15
Frankfurt am Main 15
Molfetta 15
Naples 15
Abidjan 14
Atlanta 14
Belo Horizonte 14
Charlotte 14
Zhengzhou 14
Melbourne 13
Tashkent 13
Wuhan 13
Chennai 12
Guayaquil 12
Porto Alegre 12
Amman 11
Ankara 11
Auburn Hills 11
Bologna 11
Curitiba 11
Dhaka 11
Jinan 11
Mumbai 11
Nairobi 11
Turku 11
Totale 12.230
Salva come PNG Salva come JPEG
Nome #
Anticancer kiteplatin pyrophosphate derivatives show unexpected target selectivity for DNA 222
A Pt(IV) prodrug of kiteplatin with the bone-targeting pyrophosphate ligand 200
Insights into the role of the lead/surfactant ratio in the formation and passivation of cesium lead bromide perovskite nanocrystals 197
Cytotoxicity-boosting of kiteplatin by Pt(IV) prodrugs with axial benzoate ligands 193
A model radiopharmaceutical agent targeted to translocator protein 18 kDa (TSPO) 190
Addition versus substitution in the reaction of diiodo(2,9-dimethyl-1,10-phenanthroline)platinum(II) with aromatic bases. X-ray crystal structures of the substitution products with 2-amino-pyridine and 1-methyl-cytosine 185
A new case of polymorphism in platinum(II) complexes: [PtBr2(2,9-dimethyl-1,10-phenanthroline)]? 181
Dual-acting antitumor Pt(iv) prodrugs of kiteplatin with dichloroacetate axial ligands 173
Method of treating colorectal cancer. 172
Encapsulation of lipophilic kiteplatin Pt(IV) prodrugs in PLGA-PEG micelles 171
Dinuclear Pt(II)-bisphosphonate complexes: a scaffold for multinuclear or different oxidation state platinum drugs. 165
Bisphosphonate complexation and calcium doping in silica xerogels as a combined strategy for local and controlled release of active platinum antitumor compounds 159
Antitumor trans-platinum DNA adducts: NMR and HPLC study of the interaction between a trans-Pt(iminoether) complex and the deoxy decamer d(CCTCGCTCTC).d(GAGAGCGAGG) 157
Antiviral properties and cytotoxic activity of platinum(II) complexes with 1,10-phenanthrolines and acyclovir or penciclovir 157
DNA fragment conformations in adducts with Kiteplatin 155
A new dinuclear platinum complex with a nitrogen-containing geminal bisphosphonate as potential anticancer compound specifically targeted to bone tissues 155
First-In-Class Thiosemicarbazone Metal Complexes Targeting the Sigma-2 Receptor (S2R) as an Innovative Strategy against Pancreatic Cancer 146
Cationic intermediates in oxidative addition reactions of Cl2 to [PtCl2(cis-1,4-DACH)] 146
Multi-Acting Mitochondria-Targeted Platinum(IV) Prodrugs of Kiteplatin with α-Lipoic Acid in the Axial Positions 145
Biomimetic hydroxyapatite/drug nanocrystals as potential bone substitutes with anti-tumour drug delivery properties 144
Platinum(IV) complexes of trans-1,2-diamino-4-cyclohexene: Prodrugs affording an oxaliplatin analogue that overcomes cancer resistance 144
Synthesis, Characterization, and Cytotoxicity of the First Oxaliplatin Pt(IV) Derivative Having a TSPO Ligand in the Axial Position 142
Hydroxyapatite nanocrystals as a smart, pH sensitive, delivery system for kiteplatin 142
One-Pot Synthesis of New Organometallic Compounds with Platinum-Carbon Bond 141
Novel Kiteplatin Pyrophosphate Derivatives with Improved Efficacy 140
Conformer distribution in (cis-1,4-DACH)bis(guanosine5'-phosphate)platinum(II) adducts: a reliable model for DNA adducts of antitumoral cisplatin 138
Silica xerogels and hydroxyapatite nanocrystals for the local delivery of platinum-bisphosphonate complexes in the treatment of bone tumors: A mini-review 137
Activation of antitumoral platinum prodrugs for the local treatment of bone tumors by inclusion in bioactive inorganic matrices. 137
Novel Therapeutic Agents for Bone Resorption. Part 1. Synthesis and Protonation Thermodynamics of Poly(amido-amine)s Containing Bis-phosphonate Residues 136
Synthesis and characterization of a platinum(II) complex tethered to a ligand of the peripheral benzodiazepine receptor 135
Targeting of radioactive platinum-bisphosphonate anticancer drugs to bone of high metabolic activity 135
Synthesis, characterization, and cytotoxicity of dinuclear platinum-bisphosphonate complexes to be used as prodrugs in the local treatment of bone tumours 134
Selenium-doped hydroxyapatite nanoparticles for potential application in bone tumor therapy 134
A Molecular Tool for Measuring the Electron-Acceptor Ability of Ligands from Crystallographic Data 133
Reactivity of kiteplatin with S-donor biomolecules and nucleotides 132
Sterically hindered complexes of platinum(II) with planar heterocyclic nitrogen donors. A novel complex with 1-methyl-cytosine has a spectrum of activity different from cisplatin and is able of overcoming acquired cisplatin resistance 131
Synthesis and Characterization of Platinum(II) Complexes of Diethyl [(Methylsulfinyl)methyl]phosphonate: Potential Drugs against Bone Tumors 130
Unusual DNA Binding Properties of Chelate Ring-opening Platinum Complexes 128
Influence of carrier ligand NH hydrogen bonding to the O6 and phosphate group of Guanine nucleotides in Platinum complexes with a single guanine ligand 128
Platinum Complexes with the Novel Ligand Diethyl [(Methylsulfinyl)- methyl]phosphonate (SMP): Solid-State Characterization of Potassium Trichloro(SMP)platinum(II) which, in Solution, Gives Dichloro(SMP)- platinum(II) and Potassium Chloride 127
Antitumor trans iminoether platinum di- and oligonucleotide adducts studied by NMR. 127
Cytotoxicity, cellular uptake, glutathione and DNA interactions of an antitumor large-ring PtII chelate complex incorporating the cis-1,4-diaminocyclohexane carrier ligand 125
9[(aminoalkyl)amino]nitroacridines: kinetic vs thermodynamic interactions towards platinum(II) and factors ruling their tautomeric equilibrium. 123
Back to the future with Kiteplatin: an efficacious drug against oxaliplatin-refractory colorectal cancer. 123
Dinuclear Pt(II)-bisphosphonates complexes: useful precursors of multinuclear or higher oxidation state platinum drugs. 123
Synthesis, characterization, and in vitro evaluation of a new TSPO-selective bifunctional chelate ligand 123
PEGylated solid lipid nanoparticles for brain delivery of lipophilic kiteplatin Pt(IV) prodrugs: An in vitro study 123
Role of metal ions and hydrogen bond acceptors in the tautomeric equilibrium of nitro-9[(alkylamino)amino]-acridine drugs 122
Bisphosphonate complexation and calcium doping in silica xerogels as a combined strategy for local and controlled release of active platinum antitumor compounds. 121
Synthesis, characterization, and in vitro evaluation of new coordination complexes of platinum(II) and rhenium(I) with a ligand targeting the translocator protein (TSPO) 119
A minimal structural variation can overcome tumour resistance of oxaliplatin: the case of 4,5-dehydrogenation of the cyclohexane ring 119
A novel Platinum(II) complex tethered to a ligand having high affinity for the Peripheral Benzodiazepine Receptor 118
Synthesis, characterization, and in vitro cytotoxicity of a Kiteplatin-Ibuprofen Pt(IV) prodrug 118
Computational evidence for structural consequences of kiteplatin damage on DNA 118
Influence of steric and electronic factors in the stabilization of five-coordinate ethylene complexes of platinum(II): X-ray crystal structure of [PtCl2(2,9-dimethyl-1,10-phenanthroline-5,6-dione)] 117
Assessing inter-nucleot(s)ide interactions by conformational studies of adducts between platinum complexes with carrier ligand unable to form H-bonds and guanine derivatives. 116
Preclinical evaluation of platinum-loaded hydroxyapatite nanoparticles in an embryonic zebrafish xenograft model 116
Strong, Rapid Binding of a Platinum Complex to Thymine and Uracil Under Physiological Conditions 115
A new synthetic approach for size-tunable and stable CsPbBr3 nanocubes with near-unity photoluminescence quantum yield 114
Mono- and bis-guanosine adducts of platinum complexes with carrier ligands having in-plane steric bulk: The case of 1,10-phenanthroline and 2,9-dimethyl-1,10-phenanthroline 114
Smart delivery of antitumoral platinum complexes from biomimetic hydroxyapatite nanocrystals 113
Nanocrystalline carbonate-apatites: role of Ca/P ratio on the upload and release of anticancer platinum bisphosphonates. 109
The influence of Carrier Ligand NH Hydrogen Bonding to the O6 and Phosphate Group of Guanine Nucleotides in Platinum Complexes with a Single Guanine Ligand 108
NMR investigation of the Spontaneous Thermal- and/or Photoinduced Reduction of trans Dihydroxido Pt(IV) Derivatives. 108
Cisplatin and zoledronic acid: two drugs combined in a Pt(II) complex with potential antitumor activity towards bone tumors and metastases 107
Improvement of Kiteplatin Efficacy by a Benzoato Pt(IV) Prodrug Suitable for Oral Administration 105
TSPO-seeking Pt(II)- and Pt(IV)-complexes 105
Platinum(II) Complexes with Bioactive Carrier Ligands Having High Affinity for the Translocator Protein 104
Structure and dynamics of a Platinum(II) aminophosphine complex and its nucleobase adducts 104
Dinuclear Pt(II)-bisphosphonate complexes:useful building blocks for the preparation of multinuclear or higher oxidation state platinum drugs. 101
Metallo-drugs in the Treatment of Malignant Pleural Mesothelioma 101
Bioactive Inorganic Matrices for the Local Delivery of Platinum-based Prodrugs in the Treatment of Bone Tumors 101
Antitumor drugs delivery by bone substitute biomimetic hydroxyapatite nanocrystals. 101
Platinum–bisphosphonate complexes have proven to be inactive chemotherapeutics targeted for malignant mesothelioma because of inappropriate hydrolysis 99
Platinum(II) Complexes with Antitumoral/Antiviral Aromatic Heterocycles: Effect of Glutathione upon in Vitro Cell Growth Inhibition 98
Recent findings in the chemistry of five-coordinate platinum(II) alkyne complexes. 98
Revisiting [PtCl2(cis-1,4-DACH)]: An Underestimated Antitumor Drug with Potential Application to the Treatment of Oxaliplatin-Refractory Colorectal Cancer. 98
H-Bond interactions between the NH of carrier ligand (Me3dien) and the O6 or the 5'-phosphate of guanine nucleotides in platinum complexes with a single guanine ligand. 96
Platinum-loaded, selenium-doped hydroxyapatite nanoparticles selectively reduce proliferation of prostate and breast cancer cells co-cultured in the presence of stem cells 96
Thermodynamic and mechanistic insights into translesion DNA synthesis catalyzed by Y-family DNA polymerase across a bulky double-base lesion of an antitumor platinum drug 95
Effect of chirality on the anticancer activity of Pt(II) and Pt(IV) complexes containing 1R,2R and 1S,2S enantiomers of the trans-1,2-diamino-4-cyclohexene ligand (DACHEX), an analogue of diaminocyclohexane used in oxaliplatin 95
Platinum-Based Antitumor Drugs Containing Enantiomerically Pure alpha-Trifluoromethyl Alanine as Ligand 94
Calcium-modulated release of active platinum antitumor compounds from sol-gel silica xerogels. 91
Monofunctional platinum(II) complexes and moleules of biological relevance: evaluation of steric and electronic factors in the competition for binding sites. 91
Conformational study on the five member chelate ring of new platinum complexes containing diethyl (methylsulfinyl)methylphosphonate as carrier ligand for bone tumors. 88
New Pt and Re complexes targeting the Translocator Protein 18 kDa (TSPO) as potential chemotherapics, radiopharmaceuticals, or theranostic agents 88
null 88
Molecular insights into growth and time evolution of surface states of CsPbBr3 nanoparticles synthesized by scalable room temperature approach 87
Conformational study on the five member chelate ring of new platinum complexes containing diethyl[{(methylsulfinyl)methyl}phosphonate carrier ligand for bone tumors. 87
Drug Targeting and Delivery of Platinum Chemotherapeutics ☆ 87
Implementation of Sustainable Solvents in Green Polymerization Approaches 87
Targeting of Pt(II)- and Pt(IV)-complexes to TSPO. 85
Synthesis, characterization, and biological activity of platinum(II) complexes with bioactive carrier ligands having high affinity for the Translocator Protein (TSPO) 85
In vitro targeting and imaging the Translocator Protein TSPO 18-kDa through new coordination complexes of transition metals. 84
Inclusion of Antitumoral platinum drugs in bioactive inorganic matrices to be used for the local treatment of bone tumors. 84
Synthesis, characterization, and binding to the translocator protein (18 kDa, TSPO) of a new rhenium complex as a model of radiopharmaceutical agents. 84
Bone tumor–targeted delivery of theranostic 195mPt-bisphosphonate complexes promotes killing of metastatic tumor cells 84
Delivery of platinum-based antitumor drugs by hydroxyapatite nanocrystals. 83
Synthesis, characterization, and in vitro evaluation of a new TSPO-selective metal-chelating ligand 83
In Situ Formation of Zwitterionic Ligands: Changing the Passivation Paradigms of CsPbBr3 Nanocrystals 82
Totale 12.295
Salva come PNG Salva come JPEG
Categoria #
all - tutte 75.490
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 75.490
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022974 0 0 11 9 48 66 44 57 90 79 188 382
2022/20231.812 297 163 94 176 249 236 23 188 297 23 41 25
2023/2024573 58 107 26 53 77 140 15 5 15 12 4 61
2024/20252.618 95 39 220 83 105 174 240 204 104 171 367 816
2025/20265.677 705 260 330 640 527 330 639 166 603 473 223 781
2026/2027885 186 415 284 0 0 0 0 0 0 0 0 0
Totale 18.369